|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 31/337 | |||
| A61K 38/17 | |||
| A61P 35/00 |
| (11) | Number of the document | 2601962 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12196316.9 |
| Date of filing the European patent application | 2008-10-03 | |
| (97) | Date of publication of the European application | 2013-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 07291214 | 2007-10-05 | EP |
| (72) |
Triebel, Frédéric, FR
|
| (73) |
Immutep,
Parc Club Orsay 2, Rue Jean Rostand, 91400 Orsay,
FR
|
| (54) | LAG-3 dosage regime for use in the treatement of cancer |
| LAG-3 dosage regime for use in the treatement of cancer |